Amarin Corporation PLC

AMRN:NASDAQ
RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:59 PM EST
7.94quote price arrow up+0.38 (+5.03%)
Volume
190,088
Close
7.56quote price arrow up+1.01 (+15.42%)
Volume
13,336,599
52 week range
3.36 - 20.80

...

Loading . . .

KEY STATS

  • Open7.17
  • Day High7.64
  • Day Low6.96
  • Prev Close6.55
  • 52 Week High20.80
  • 52 Week High Date01/24/20
  • 52 Week Low3.36
  • 52 Week Low Date09/24/20
  • Market Cap2,939.55M
  • Shares Out388.83M
  • 10 Day Average Volume6.95M
  • Dividend-
  • Dividend Yield-
  • Beta2.50
  • 1 Year % Change-62.61

RATIOS/PROFITABILITY

  • EPS (TTM)-0.05
  • P/E (TTM)-161.88
  • Fwd P/E (NTM)-87.91
  • EBITDA (MRQ)-20.01M
  • ROE (MRQ)-2.70%
  • Revenue (MRQ)590.09M
  • Gross Margin (MRQ)78.42%
  • Net Margin (MRQ)-2.69%
  • Debt To Equity (MRQ)1.56%

EVENTS

  • Earnings Date02/27/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Amarin Corporation PLC News

There is no recent news for this security.

Latest AMRN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Amarin Corporation plc is a biopharmaceutical company with operations in lipid science focused on the commercialization and development of therapeutics for cardiovascular health. The Company operates through the development and commercialization of Vascepa segment. The Company's lead product, Vascepa (icosapent ethyl) capsule, is approved by the United States Food and Drug Administration (FDA) for use as an adjunct to diet to reduce triglyceride levels in adult patients with...
Lars Ekman M.D., Ph.D.
Non-Executive Chairman
John Thero CPA
President
Michael Kalb
Chief Financial Officer
Joseph Kennedy J.D.
Executive Vice President
Address
Gemini House, Bartholomews Walk
Dublin
FK7 9JQ
Ireland